QCM Cayman’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,838
Closed -$285K 77
2023
Q1
$285K Buy
+1,838
New +$297K 1.78% 23
2022
Q2
Sell
-1,157
Closed -$205K 66
2022
Q1
$205K Buy
+1,157
New +$197K 0.9% 62
2018
Q3
Sell
-2,643
Closed -$321K 148
2018
Q2
$321K Buy
+2,643
New +$330K 1.49% 22
2017
Q2
Sell
-9,125
Closed -$1.14M 283
2017
Q1
$1.14M Buy
+9,125
New +$1.09M 0.21% 115
2016
Q3
Sell
-2,477
Closed -$300K 280
2016
Q2
$300K Buy
+2,477
New +$281K 0.13% 128
2014
Q2
Sell
-2,306
Closed -$227K 295
2014
Q1
$227K Sell
2,306
-1,276
-36% -$118K 0.05% 236
2013
Q4
$328K Buy
+3,582
New +$330K 0.11% 68

Other funds holding JNJ

QCM Cayman's JNJ Position: Q2 2023 in Review

QCM Cayman sold out of Johnson & Johnson (JNJ) in Q2 2023, closing a stake of 1,838 shares — an estimated $285K sold.

QCM Cayman first reported a position in JNJ in Q4 2013 and held it in 7 quarters. The position peaked at $1.14M in Q1 2017. 3,751 funds tracked by Wall St. Rank hold JNJ as of Q2 2023.

  • QCM Cayman reported no remaining Johnson & Johnson position as of Q2 2023 after selling out during the quarter.
  • QCM Cayman sold 1,838 Johnson & Johnson shares in Q2 2023, an estimated $285K.
  • QCM Cayman first reported a position in Johnson & Johnson in Q4 2013 and held it in 7 quarters.
  • QCM Cayman's Johnson & Johnson position peaked at $1.14M in Q1 2017.
  • 3,751 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2023.

Based on QCM Cayman's 13F filing for Q2 2023, filed 25 Jul 2023.